Your browser doesn't support javascript.
loading
Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial.
Cappuccini, Federica; Bryant, Richard; Pollock, Emily; Carter, Lucy; Verrill, Clare; Hollidge, Julianne; Poulton, Ian; Baker, Megan; Mitton, Celia; Baines, Andrea; Meier, Armin; Schmidt, Guenter; Harrop, Richard; Protheroe, Andrew; MacPherson, Ruth; Kennish, Steven; Morgan, Susan; Vigano, Selena; Romero, Pedro J; Evans, Thomas; Catto, James; Hamdy, Freddie; Hill, Adrian V S; Redchenko, Irina.
Affiliation
  • Cappuccini F; Nuffield Department of Medicine, The Jenner Institute, Oxford University, Oxford, UK.
  • Bryant R; Nuffield Department of Surgical Sciences, Oxford University, Oxford, UK.
  • Pollock E; Department of Urology, Churchill Hospital, Oxford, UK.
  • Carter L; Nuffield Department of Medicine, The Jenner Institute, Oxford University, Oxford, UK.
  • Verrill C; Nuffield Department of Medicine, The Jenner Institute, Oxford University, Oxford, UK.
  • Hollidge J; Nuffield Department of Surgical Sciences, Oxford University, Oxford, UK.
  • Poulton I; Oxford NIHR Biomedical Research Centre, Oxford University, Oxford, UK.
  • Baker M; Nuffield Department of Surgical Sciences, Oxford University, Oxford, UK.
  • Mitton C; Nuffield Department of Medicine, The Jenner Institute, Oxford University, Oxford, UK.
  • Baines A; Nuffield Department of Medicine, The Jenner Institute, Oxford University, Oxford, UK.
  • Meier A; Nuffield Department of Medicine, The Jenner Institute, Oxford University, Oxford, UK.
  • Schmidt G; Nuffield Department of Medicine, The Jenner Institute, Oxford University, Oxford, UK.
  • Harrop R; Definiens AG, Munchen, Bayern, Germany.
  • Protheroe A; Definiens AG, Munchen, Bayern, Germany.
  • MacPherson R; Oxford Biomedica Plc, Oxford, UK.
  • Kennish S; Department of Oncology, Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford, UK.
  • Morgan S; Department of Radiology, Churchill Hospital, Oxford, UK.
  • Vigano S; Department of Radiology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Romero PJ; Department of Pathology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Evans T; Oncology, University Hospital of Lausanne, Lausanne, Switzerland.
  • Catto J; Oncology, University Hospital of Lausanne, Lausanne, Switzerland.
  • Hamdy F; Vaccitech UK Limited, Oxford, UK.
  • Hill AVS; Academic Urology Unit, The University of Sheffield, Sheffield, UK.
  • Redchenko I; Nuffield Department of Surgical Sciences, Oxford University, Oxford, UK.
J Immunother Cancer ; 8(1)2020 06.
Article in En | MEDLINE | ID: mdl-32591433
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / T-Lymphocytes / Vaccination / Cancer Vaccines / Immunogenicity, Vaccine Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: J Immunother Cancer Year: 2020 Document type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / T-Lymphocytes / Vaccination / Cancer Vaccines / Immunogenicity, Vaccine Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: J Immunother Cancer Year: 2020 Document type: Article Affiliation country: United kingdom